Insight
Discovery Needs a Clinical Perspective. NAMs Deliver It.
Human-relevant NAMs generate the predictive insights needed to guide development decisions.
This case study demonstrates how predictive, human-relevant NAMs support IND-enabling safety assessment for biologics and bispecific antibodies, enabling earlier risk identification, stronger regulatory confidence, and a clearer path to clinical success.
Download Document
Download Document
Related Insights
Specifica Antibody Discovery Campaigns
Specifica Library Platform Transfer
Specifica Affinity Maturation & Developability Optimization
Discovery Sciences – Innovative Antibody Drug Discovery Services
Immunogenicity Assessment and Functional Testing of Candidate Therapeutics
Presented by Chloe Ackaert, PhD at AAPS PharmSci360 in 2023
Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis
Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs
In vitro functional evaluation of immuno-oncology drug candidates in customized bioassays
Monoclonal Antibodies Reagents
